Moreover, the expression levels of proteasome genes, such as PSMB6, have been observed to increase in many types of cancers, suggesting that PSMB6 could potentially serve as a molecular therapeutic target (Guo et al., 2022; Bruzzoni-Giovanelli et al., 2015; Ding et al., 2020). This evidence concerns the gene PSMB6 and cancer.